Literature DB >> 32410276

RNA conversion of COVID-19 in respiratory and alimentary specimens during asymptomatic convalescence.

Yichi Zhang1, Tingting Su2, Bing Han1, Miao Huang1, Xueshi Zhou2, Jian Wang1, Yuanwang Qiu2, Yingbin Liu3, Jinyang Gu1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32410276      PMCID: PMC7272797          DOI: 10.1111/jgh.15095

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.369


× No keyword cloud information.
To the Editor, Few studies concerning novel coronavirus disease 2019 (COVID‐19) have focused on the follow‐up of recovered patients, especially subclinical infected individuals, which may lead to a serious threat to public health if neglected. Here, we report a recovered COVID‐19 patient with both nasopharyngeal and anal swabs converting to be positive among an infected family cluster. On February 8, 2020, a 46‐year‐old woman (patient 6) was admitted to Wuxi Fifth Affiliated Hospital of Jiangnan University due to positive COVID‐19 reverse transcriptase‐polymerase chain reaction (RT‐PCR) result for nasopharyngeal swab after dining with family members (patients 1–5, relatives 1–5) for consecutive 5 days since January 27, including her father (patient 1) who attended a banquet with a later confirmed imported case (index patient) of COVID‐19 infection from Japan on January 25. Patients 1–5 were all confirmed positive before or after patient 6 and admitted to the same hospital while relatives 1–5 were exempted from infection (Fig. 1 and Table 1). She experienced a transient fever of peak value of 37.8 °C during admission, which normalized on February 13. Routine blood test manifested no decrease in white blood cell count or lymphocyte count. Meanwhile, chest computed tomography (CT) images did not present with typical abnormalities such as ground‐grass opacities or consolidation. Antiviral regimens containing inhaled interferon, oral lopinavir/ritonavir tablets, and arbidol were given depending on the patient's condition. From February 15, RT‐PCR results were negative for four nasopharyngeal swabs and one anal swab, and she was discharged on February 23.
FIGURE 1

Timeline of epidemiological and clinical characteristics of COVID‐19 patients in a family cluster. The figure shows the epidemic investigation of patients 1–6 and relatives 1–5, including clinical symptoms, detections of COVID‐19, contact histories, and hospitalization information. Grids in different colors represent the contact histories with patient 1, the status of quarantine, or hospitalization. , Home quarantine; , centralized quarantine; , hospitalized; , contact with patient 1; , discharged; , out of quarantine. Beginning of symptoms indicates the onset of COVID‐19‐related symptoms such as runny nose, cough, and muscle ache. Typical symptoms, including fever and diarrhea, are emphasized by symbols. If the examination of swabs is positive, the “P” in the circle is used; otherwise, the “N” in the circle is used. , Fever; , beginning of symptoms; , diarrhea; , positive/negative nasopharyngeal swab; , positive/negative anal swab.

TABLE 1

Characteristics, clinical outcomes, and treatment of patients 1–6

Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6
Number of hospitalization1st2nd
SexMaleFemaleMaleFemaleMaleFemale
Age (years)745054494946
OccupationRetiredWorkerEmployeeEmployeeEmployeeJobless
Comorbidities

Hypertension

Diabetes

HypertensionHypertensionHypertensionNoNo
SmokersYesNoNoNoNoNo
History of residence in WuhanNoNoNoNoNoNo
FeverYesYesYesYesYesYesNo
Peak of temperature (°C)39.538.238.038.337.837.836.9
Duration of fever (days)2693527
Dry coughYesYesNoYesYesNoNo
DyspneaYesNoNoNoNoNoNo
DiarrheaYesYesNoNoNoNoNo
Nausea and vomitingNoNoNoNoNoNoNo
Dizziness and headacheYesNoNoNoNoNoNo
Myalgia and abdominal painNoYesYesNoNoNoNo
Fatigue and anorexiaYesNoNoNoNoNoNo
Nasopharyngeal swabPositivePositivePositivePositivePositivePositivePositive
Anal swabNegativeNegativeNegativeNegativeNegativeNegativePositive
Chest CT imagesBilateral pneumoniaNormalNormalNormalNormalNormalNormal
Onset of symptom or positive RT‐PCR to hospital admission (days)2834211
Hospitalization time (days)291715171516> 11
ComplicationsNoNoAbnormal liver functionNoNoNoNo
Oxygen therapyYesNoNoNoNoNoNo
Antibiotic treatmentYesNoNoNoNoNoNo
Antiviral treatmentYesYesYesYesYesYesNo
Atomization treatment of ɑ‐interferonYesYesYesYesYesYesNo
GlucocorticoidsYesNoNoNoNoNoNo
Traditional Chinese medicine treatmentYesYesYesYesYesYesNo

CT, computed tomography; RT‐PCR, reverse transcriptase‐polymerase chain reaction.

Timeline of epidemiological and clinical characteristics of COVID‐19 patients in a family cluster. The figure shows the epidemic investigation of patients 1–6 and relatives 1–5, including clinical symptoms, detections of COVID‐19, contact histories, and hospitalization information. Grids in different colors represent the contact histories with patient 1, the status of quarantine, or hospitalization. , Home quarantine; , centralized quarantine; , hospitalized; , contact with patient 1; , discharged; , out of quarantine. Beginning of symptoms indicates the onset of COVID‐19‐related symptoms such as runny nose, cough, and muscle ache. Typical symptoms, including fever and diarrhea, are emphasized by symbols. If the examination of swabs is positive, the “P” in the circle is used; otherwise, the “N” in the circle is used. , Fever; , beginning of symptoms; , diarrhea; , positive/negative nasopharyngeal swab; , positive/negative anal swab. Characteristics, clinical outcomes, and treatment of patients 1–6 Hypertension Diabetes CT, computed tomography; RT‐PCR, reverse transcriptase‐polymerase chain reaction. Patient 6 was required to continue centralized quarantine for another 14 days. Unfortunately, the RT‐PCR test of nasopharyngeal swab sample demonstrated recurrent positive 1 week after discharge (March 1) while anal swab test kept negative, so she was readmitted asymptomatically. It was noteworthy that the subsequent anal swab tests turned positive (March 3 and March 6) after readmission while the synchronous nasopharyngeal swabs were negative and positive, respectively. Chest CT scan performed on March 9 displayed no positive findings. On March 11 and 12, both nasopharyngeal and anal swabs RT‐PCR results were negative. After three consecutive negative nasopharyngeal RT‐PCR tests, she was prescribed home quarantine since March 13, with subsequent two negative nasopharyngeal RNA tests after 2 and 4 weeks. Meanwhile, the other infected family members were all discharged, and none of them got re‐infection like patient 6. Much of the research emphasis on infection control for COVID‐19 seems to be overestimated on respiratory droplet transmission and critically ill cases. However, there is still little evidence summarizing the alternative transmission route, and the role of asymptomatic carriers or subclinical patients. COVID‐19 was primarily discovered in respiratory specimens, and afterwards, the viral nucleic acids were identified in patients' urine, stool, gastrointestinal mucosa, and serum. , As far as patient 6 was concerned, she received four nasopharyngeal but only one anal swab test during hospitalization, which was likely to be false negative and led to the neglect of gastrointestinal tract monitoring. Xie et al. mentioned that nearly 14% “re‐positive” patients of all discharged patients in Guangzhou were detected by increasing the nasal swab tests. Another research also raised that enhancing nasal swab tests could eliminate the false negative rate since higher viral loads were detected in the upper respiratory tract. On the other hand, some researchers advocated that diarrhea should be regarded as a vital symptom of COVID‐19 infection. , Others mentioned that fecal–oral transmission may be a potential route of COVID‐19 outbreak. , Therefore, a reassessment of latent and asymptomatic patients as sources of infection for the current prevention and control measures is warranted to eventually eliminate the disease. With the increasing recovered COVID‐19 cases, some recurrent positive tests of viral nucleic acids were reported in either nasopharyngeal or anal swab after discharge, , , whereas our study for the first time described recurrent COVID‐19 in both respiratory and alimentary specimens at the same time during asymptomatic convalescence. Positive results in both nasopharyngeal and anal swabs after recovery demonstrated the low possibility of false positives. Moreover, whether positive samples of two or more sites is indicative of the existence of active virus, as well as its potential possibility of transmission, remains unknown. A recent study declared that the positive ratio of nucleic acid tests was only 47.4% in the presumptive patients for COVID‐19. The asymptomatic infected patients may have been overlooked by nucleic acid tests only, which may be retrieved by applying antibody detection. It is not clear whether the current discharge criteria were too lax and incomplete, or a secondary infection did occur. Taken together, centralized quarantine instead of home quarantine after discharge, appropriate extension of quarantine period, and increasing the frequency of nucleic acid tests at multiple sites accompanied with chest CT scanning during hospitalization as well as convalescent phase should be considered.
  13 in total

1.  Antibody testing will enhance the power and accuracy of COVID-19-prevention trials.

Authors:  Marc Lipsitch; Rebecca Kahn; Michael J Mina
Journal:  Nat Med       Date:  2020-06       Impact factor: 53.440

2.  Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus.

Authors:  Weicheng Liang; Zhijie Feng; Shitao Rao; Cuicui Xiao; Xingyang Xue; Zexiao Lin; Qi Zhang; Wei Qi
Journal:  Gut       Date:  2020-02-26       Impact factor: 23.059

3.  SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19.

Authors:  Y Song; P Liu; X L Shi; Y L Chu; J Zhang; J Xia; X Z Gao; T Qu; M Y Wang
Journal:  Gut       Date:  2020-03-05       Impact factor: 23.059

4.  SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.

Authors:  Lirong Zou; Feng Ruan; Mingxing Huang; Lijun Liang; Huitao Huang; Zhongsi Hong; Jianxiang Yu; Min Kang; Yingchao Song; Jinyu Xia; Qianfang Guo; Tie Song; Jianfeng He; Hui-Ling Yen; Malik Peiris; Jie Wu
Journal:  N Engl J Med       Date:  2020-02-19       Impact factor: 91.245

5.  RNA conversion of COVID-19 in respiratory and alimentary specimens during asymptomatic convalescence.

Authors:  Yichi Zhang; Tingting Su; Bing Han; Miao Huang; Xueshi Zhou; Jian Wang; Yuanwang Qiu; Yingbin Liu; Jinyang Gu
Journal:  J Gastroenterol Hepatol       Date:  2020-06-26       Impact factor: 4.369

6.  Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.

Authors:  Wei Zhang; Rong-Hui Du; Bei Li; Xiao-Shuang Zheng; Xing-Lou Yang; Ben Hu; Yan-Yi Wang; Geng-Fu Xiao; Bing Yan; Zheng-Li Shi; Peng Zhou
Journal:  Emerg Microbes Infect       Date:  2020-02-17       Impact factor: 7.163

7.  COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission.

Authors:  Jinyang Gu; Bing Han; Jian Wang
Journal:  Gastroenterology       Date:  2020-03-03       Impact factor: 22.682

8.  Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests.

Authors:  Chunbao Xie; Lingxi Jiang; Guo Huang; Hong Pu; Bo Gong; He Lin; Shi Ma; Xuemei Chen; Bo Long; Guo Si; Hua Yu; Li Jiang; Xingxiang Yang; Yi Shi; Zhenglin Yang
Journal:  Int J Infect Dis       Date:  2020-02-27       Impact factor: 3.623

9.  False negative rate of COVID-19 is eliminated by using nasal swab test.

Authors:  Chaojun Xie; Jianyun Lu; Di Wu; Lin Zhang; Hongjun Zhao; Boqi Rao; Zhicong Yang
Journal:  Travel Med Infect Dis       Date:  2020-04-11       Impact factor: 6.211

10.  Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report.

Authors:  Dabiao Chen; Wenxiong Xu; Ziying Lei; Zhanlian Huang; Jing Liu; Zhiliang Gao; Liang Peng
Journal:  Int J Infect Dis       Date:  2020-03-05       Impact factor: 3.623

View more
  2 in total

1.  Risk factors for prolonged nucleic acid conversion time in patients with COVID-19.

Authors:  Kadir Canoglu; Tayfun Caliskan; Ecem Sinmez
Journal:  Int J Health Sci (Qassim)       Date:  2022 Mar-Apr

2.  RNA conversion of COVID-19 in respiratory and alimentary specimens during asymptomatic convalescence.

Authors:  Yichi Zhang; Tingting Su; Bing Han; Miao Huang; Xueshi Zhou; Jian Wang; Yuanwang Qiu; Yingbin Liu; Jinyang Gu
Journal:  J Gastroenterol Hepatol       Date:  2020-06-26       Impact factor: 4.369

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.